Does this patient with diabetes have large-fiber peripheral neuropathy?

JAMA

Volumn 303, Issue 15, 2010, Pages 1526-1532

  Jamil N, Kanji ^a,c   Anglin, Rebecca E S ^a   Hunt, Dereck L ^a,b   Panju, Akbar ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ACHILLES REFLEX; ARTICLE; CLINICAL EVALUATION; CLINICAL EXAMINATION; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; EMBASE; FOOT ULCER; GLUCOSE BLOOD LEVEL; HUMAN; LARGE FIBER PERIPHERAL NEUROPATHY; MEDLINE; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PARESTHESIA; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PREDICTION; PRESSURE SENSATION; PRIORITY JOURNAL; PROBABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STANDARD; STRUCTURED QUESTIONNAIRE; SYSTEMATIC REVIEW; VIBRATION SENSE;

EID: 77951185895     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.428     Document Type: Article

References (38)

1. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care. 1994;17(6):557-560.
2. Currie CJ, Poole CD, Woehl A, et al. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia. 2006;49(10):2272-2280.
3. Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25(12):2238-2243.
4. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22(3):382-387.
5. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13(5):513-521.
6. McGee S. Evidence Based Physical Diagnosis. 2nd ed. St Louis, MO: Saunders Elsevier; 2007.
7. Kumar S, Ashe HA, Parnell LN, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med. 1994;11(5):480-484.
8. McIntosh A, Peters J, Young R, et al. Clinical Guidelines for Type 2 Diabetes: Prevention and Management of Foot Problems. 2003. http://guidance. nice.org.uk/CG10/Guidance/pdf/English. Accessed December 13, 2009.
9. Scadding J. Neuropathic pain. Adv Clin Neurosci Rehabil. 2003;3(2):8-14.
10. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988;11(1):21-32.
11. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24(2):250-256.
12. Butalia S, Palda VA, Sargeant RJ, Detsky AS, Mourad O. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA. 2008;299(7):806-813.
13. Saltzman CL, Rashid R, Hayes A, et al. 4.5-Gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients. J Bone Joint Surg Am. 2004;86-A(4):717-723.
14. Birke JA, Sims DS. Plantar sensory threshold in the ulcerative foot. Lepr Rev. 1986;57(3):261-267.
15. Smieja M, Hunt DL, Edelman D, Etchells E, Cornuz J, Simel DL; International Cooperative Group for Clinical Examination Research. Clinical examination for the detection of protective sensation in the feet of diabetic patients. J Gen Intern Med. 1999;14(7):418-424.
16. International Working Group on the Diabetic Foot. Practical guidelines on the management and prevention of the diabetic foot. http://www.iwgdf.org/index. php?option=com-content&task=view&id=28&Itemid=24. Accessed December 4, 2008.
17. National Diabetes Education Program. Feet Can Last a Lifetime: A Health Care Provider's Guide to Preventing Diabetes Foot Problems. http://ndep.nih.gov/ media/Feet-HCGuide.pdf. Accessed December 4, 2008.
18. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-228.
19. Perkins BA, Bril V. Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol. 2003;114(7):1167-1175.
20. Park TS, Park JH, Baek HS. Can diabetic neuropathy be prevented? Diabetes Res Clin Pract. 2004;66(suppl 1):S53-S56.
21. Bril V. Current treatment of diabetic neuropathy. Can J Diabetes Care. 2000;24(suppl 2):67-75.
22. Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology. 1991;41(6):799-807.
23. Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score: validation and reliability study. Neurology. 1999;53(8):1660-1664.
24. Hoitsma E, Reulen JP, de Baets M, Drent M, Spaans F, Faber CG. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci. 2004;227(1):119-130.
25. Tavee J, Zhou L. Small fiber neuropathy: a burning problem. Cleve Clin J Med. 2009;76(5):297-305.
26. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44(8):763-770.
27. Beghi E, Treviso M, Ferri P, Di Mascio R. Diagnosis of diabetic polyneuropathy: correlation between clinical and instrumental findings and assessment of simple diagnostic criteria. Ital J Neurol Sci. 1988;9(6):577-582.
28. Gentile S, Turco S, Corigliano G, Marmo R; SIMSDN Group. Simplified diagnostic criteria for diabetic distal polyneuropathy: preliminary data of a multicentre study in the Campania region. Acta Diabetol. 1995;32(1):7-12.
29. Shin JB, Seong YJ, Lee HJ, Kim SH, Park JR. Foot screening technique in a diabetic population. J Korean Med Sci. 2000;15(1):78-82.
30. Lee S, Kim H, Choi S, Park Y, Kim Y, Cho B. Clinical usefulness of the two-site Semmes-Weinstein monofilament test for detecting diabetic peripheral neuropathy. J Korean Med Sci. 2003;18(1):103-107.
31. Hsu WC, Chiu YH, Chiu HC, Liou HH, Jeng YC, Chen TH. Two-stage community-based screening model for estimating prevalence of diabetic polyneuropathy (KCIS No. 6). Neuroepidemiology. 2005;25(1):1-7.
32. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan Neuropathy Screening Instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108(5):477-481.
33. Costa LA, Maraschin JF, Xavier de Castro JH, Gross JL, Friedman R. A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patients. Diabetes Res Clin Pract. 2006;73(3):292-297.
34. Papanas N, Giassakis G, Papatheodorou K, et al. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications. 2007;21(6):353-358.
35. Maser RE, Nielsen VK, Bass EB, et al. Measuring diabetic neuropathy: assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care. 1989;12(4):270-275.
36. O'Neill J, McCann SM, Lagan KM. Tuning fork (128 Hz) vs neurothesiometer: a comparison of methods of assessing vibration sensation in patients with diabetes mellitus. Int J Clin Pract. 2006;60(2):174-178.
37. Dyck PJ, Sherman WR, Mallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myoinositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):590-596.
38. Boulton AJ. Management of diabetic peripheral neuropathy. Can J Diabetes Care. 2000;24(suppl 2):67-75.